HighCape Capital

HighCape Partners Management, L.P. is a venture capital firm based in Baltimore, Maryland, with an additional office in New York, New York. Founded in 2013, the firm specializes in growth equity investments in commercial-stage life science companies that are in the early stages of revenue generation or product launch. HighCape focuses on firms that offer high-margin life science products and have a clear path to commercialization, aiming to transform them into scalable commercial entities. The firm primarily targets sectors such as healthcare devices, pharmaceuticals, and biotechnology. HighCape is a Registered Investment Adviser and manages multiple funds to support its investment strategies.

Focus

G20 G7 USA North America US East Coast Show more

http://highcape.com

https://crunchbase.com/organization/highcape-partners

https://linkedin.com/company/highcape-partners

https://pitchbook.com/profiles/investor/61236-28

https://twitter.com/highcapevc

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=254702700

Jennifer Barretta

Partner

Charles Hart

Operating Partner

Kevin Rakin

Co-Founder & Partner

Carol Reed

Operating Partner

Dean Tozer

Partner

Matt Zuga

Partner

Past deals in Maryland

Elutia

Venture Round in 2017

Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.